These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 8793597)
1. Heparin-coated bypass circuits in cardiopulmonary bypass: improved biocompatibility or not. Levy M; Hartman AR Int J Cardiol; 1996 Apr; 53 Suppl():S81-7. PubMed ID: 8793597 [TBL] [Abstract][Full Text] [Related]
2. Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? Mahmood S; Bilal H; Zaman M; Tang A Interact Cardiovasc Thorac Surg; 2012 Apr; 14(4):406-14. PubMed ID: 22228288 [TBL] [Abstract][Full Text] [Related]
3. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass. Tamim M; Demircin M; Guvener M; Peker O; Yilmaz M Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115 [TBL] [Abstract][Full Text] [Related]
9. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Moen O; Høgåsen K; Fosse E; Dregelid E; Brockmeier V; Venge P; Harboe M; Mollnes TE Ann Thorac Surg; 1997 Jan; 63(1):105-11. PubMed ID: 8993250 [TBL] [Abstract][Full Text] [Related]
10. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model. Bannan S; Danby A; Cowan D; Ashraf S; Gesinde M; Martin P Eur J Cardiothorac Surg; 1997 Aug; 12(2):268-75. PubMed ID: 9288518 [TBL] [Abstract][Full Text] [Related]
11. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass. de Vroege R; Huybregts R; van Oeveren W; van Klarenbosch J; Linley G; Mutlu J; Jansen E; Hack E; Eijsman L; Wildevuur C Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987 [TBL] [Abstract][Full Text] [Related]
12. Superior biocompatibility of heparin-bonded circuits in pediatric cardiopulmonary bypass. Ozawa T; Yoshihara K; Koyama N; Yamazaki S; Takanashi Y Jpn J Thorac Cardiovasc Surg; 1999 Dec; 47(12):592-9. PubMed ID: 10658376 [TBL] [Abstract][Full Text] [Related]
13. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits. Borowiec J; Bagge L; Saldeen T; Thelin S Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816 [TBL] [Abstract][Full Text] [Related]
14. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients. Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050 [TBL] [Abstract][Full Text] [Related]
15. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit. Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027 [TBL] [Abstract][Full Text] [Related]
16. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass. Gu YJ; van Oeveren W; Akkerman C; Boonstra PW; Huyzen RJ; Wildevuur CR Ann Thorac Surg; 1993 Apr; 55(4):917-22. PubMed ID: 8466349 [TBL] [Abstract][Full Text] [Related]
17. High and low heparin dose with heparin-coated cardiopulmonary bypass: activation of complement and granulocytes. Ovrum E; Mollnes TE; Fosse E; Holen EA; Tangen G; Ringdal MA; Videm V Ann Thorac Surg; 1995 Dec; 60(6):1755-61. PubMed ID: 8787476 [TBL] [Abstract][Full Text] [Related]